Cargando…
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
BACKGROUND: A considerable proportion of estrogen receptor (ER)-positive breast cancer recurs despite tamoxifen treatment, which is a serious problem commonly encountered in clinical practice. We tried to find novel prognostic markers in this subtype of breast cancer. METHODS: We performed array com...
Autores principales: | Han, Wonshik, Han, Mi-Ryung, Kang, Jason Jongho, Bae, Ji-Yeon, Lee, Ji Hyun, Bae, Young Ju, Lee, Jeong Eon, Shin, Hyuk-Jae, Hwang, Ki-Tae, Hwang, Sung-Eun, Kim, Sung-Won, Noh, Dong-Young |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459182/ https://www.ncbi.nlm.nih.gov/pubmed/16608533 http://dx.doi.org/10.1186/1471-2407-6-92 |
Ejemplares similares
-
Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2007) -
Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer
por: Lee, Jeong Eon, et al.
Publicado: (2005) -
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
por: Lee, Eun-Shin, et al.
Publicado: (2016) -
Application of a target array Comparative Genomic Hybridization to prenatal diagnosis
por: Park, Ji Hyeon, et al.
Publicado: (2010) -
Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data
por: Choi, Sung Hyouk, et al.
Publicado: (2020)